Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.71 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29492458 | 1.00 | TYR (0.71) | TYRTRPA1LMNACHRM1SLC6A2 | |
| SCHEMBL28430447 | 0.90 | TYR (0.79) | TYRTRPA1LMNACHRM1SLC6A2 | |
| SCHEMBL28311703 | 0.85 | TYR (0.66) | TYRTRPA1LMNACHRM1SLC6A2 | |
| SCHEMBL10899030 | 0.85 | TYR (0.51) | TYRTRPA1LMNACHRM1SLC6A2 | |
| SCHEMBL369337 | 0.83 | TYR (1.00) | TYRESR1PDCD1ESR2CD274 | |
| SCHEMBL19806855 | 0.83 | TYR (0.49) | TYRTRPA1LMNACHRM1SLC6A2 | |
| SCHEMBL29394395 | 0.83 | TYR (1.00) | TYRESR1PDCD1ESR2CD274 | |
| SCHEMBL18815425 | 0.83 | TYR (1.00) | TYRESR1PDCD1ESR2CD274 | |
| SCHEMBL21830514 | 0.82 | TYR (0.62) | TYRTRPA1LMNACHRM1SLC6A2 | |
| SCHEMBL29492429 | 0.82 | TYR (0.62) | TYRTRPA1LMNACHRM1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4142680-B1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | UNILEVER IP HOLDINGS B V (NL) | 2023-10-18 | — | — | EP | disclosed |
| US-11759412-B2 | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids | CONOPCO, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20230181433-A1 | PERSONAL CARE COMPOSITIONS WITH GLUTATHIONE PRECURSOR COMPRISING 4-SUBSTITUTED RESORCINOLS AND AMINO ACIDS | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-06-15 | — | — | US | disclosed |
| US-20230165772-A1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-06-01 | — | — | US | disclosed |
| EP-4142680-A1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | Unilever IP Holdings B.V. (NL) | 2023-03-08 | — | — | EP | disclosed |
| US-11260005-B2 | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids | CONOPCO, INC. (US) | 2022-03-01 | — | — | US | disclosed |
| WO-2021219378-A1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | UNILEVER IP HOLDINGS B.V. (NL) | 2021-11-04 | — | — | WO | disclosed |
| EP-3558246-B1 | PERSONAL CARE COMPOSITIONS WITH GLUTATHIONE PRECURSOR COMPRISING 4-SUBSTITUTED RESORCINOLS AND AMINO ACIDS | UNILEVER IP HOLDINGS B V (NL) | 2021-10-20 | — | — | EP | disclosed |
| US-20200108000-A1 | PERSONAL CARE COMPOSITIONS WITH GLUTATHIONE PRECURSOR COMPRISING 4-SUBSTITUTED RESORCINOLS AND AMINO ACIDS | CONOPCO, INC., D/B/A UNILEVER (US) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11260005-B2 | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids | GPX1, GPX4, GCLC | TYR 6/4885TRPA1 2539/4885LMNA 4469/4885 |
| US-20230165772-A1 | STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE | NAA40, CRAT, NQO1 | TYR 139/4885TRPA1 317/4885LMNA 3296/4885 |
| US-20230181433-A1 | PERSONAL CARE COMPOSITIONS WITH GLUTATHIONE PRECURSOR COMPRISING 4-SUBSTITUTED RESORCINOLS AND AMINO ACIDS | GPX1, GPX4, GCLC | TYR 6/4885TRPA1 2539/4885LMNA 4469/4885 |
| US-11759412-B2 | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids | GPX1, GPX4, GCLC | TYR 6/4885TRPA1 2539/4885LMNA 4469/4885 |
| US-20200108000-A1 | PERSONAL CARE COMPOSITIONS WITH GLUTATHIONE PRECURSOR COMPRISING 4-SUBSTITUTED RESORCINOLS AND AMINO ACIDS | GPX1, GPX4, GCLC | TYR 6/4885TRPA1 2539/4885LMNA 4469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.